Celebrating World Diabetes Day 2023

Access to Diabetes Care

The theme of World Diabetes Day 2023 is "Access to Diabetes Care". We support the millions of individuals managing diabetes and recognize the crucial and continuous research endeavours directed towards conquering the disease. Timely access to reliable information and adequate care is instrumental in ensuring swift treatment and successful disease management.

Elsevier empowers you with knowledge and valuable information to support the management of diabetes. On this World Diabetes Day 2023 we present some of the cutting-edge research published in our Endocrinology journals.

Enjoy free access to these articles until February 29, 2024.

Article collection

AACE Clinical Case Reports

• ●

  Euglycemic Diabetic Ketoacidosis With COVID-19 Infection in Patients With Type 2 Diabetes Taking SGLT2 Inhibitors(opens in new tab/window)

• ●

  Diabetic Ketoacidosis in a Patient With Type I Diabetes Treated With a Closed-Loop Sensor–Augmented Insulin Infusion System(opens in new tab/window)

Annales d'Endocrinologie

• ●

  Dual GIP/GLP-1 receptor agonists: New advances for treating type-2 diabetes(opens in new tab/window)

• ●

  Epidemiology and health impact of diabetes in France(opens in new tab/window)

Best Practice & Research Clinical Endocrinology & Metabolism

• ●

  Genetics and epigenetics of autoimmune thyroid diseases: Translational implications(opens in new tab/window)

• ●

  Genomic and epigenomic profile of thyroid cancer(opens in new tab/window)

Bone

• ●

  Role of advanced glycation endproducts in bone fragility in type 1 diabetes(opens in new tab/window)

• ●

  Associations of estrogen therapy and non-estrogen anti-resorptive therapy with diabetes mellitus risk: A classical and Bayesian meta-analysis(opens in new tab/window)

Bone Reports

• ●

  Effects of empagliflozin on markers of calcium and phosphate homeostasis in patients with type 2 diabetes – Data from a randomized, placebo-controlled study(opens in new tab/window)

• ●

  Type 2 diabetes alters the viscoelastic behavior and macromolecular composition of vertebra(opens in new tab/window)

Canadian Journal of Diabetes

• ●

  Acceptability of Self-Management Group Education to Reduce Fear of Hypoglycemia as a Barrier to Physical Activity in Adults With Type 1 Diabetes: A Mixed Methods Approach(opens in new tab/window)

• ●

  Barriers to Physical Activity in Children and Adults Living With Type 1 Diabetes: A Complex Link With Real-life Glycemic Excursions(opens in new tab/window)

Current Opinion in Endocrine and Metabolic Research

• ●

  Designing next-generation islet-like cells from human pluripotent stem cells: Advances in overcoming allorejection and recurrent type 1 diabetes(opens in new tab/window)

• ●

  Clinical efficacy and mechanism of action of medical devices for obesity and type 2 diabetes(opens in new tab/window)

Cytokine and Growth Factor Reviews

• ●

  The roles of cell-cell and organ-organ crosstalk in the type 2 diabetes mellitus associated inflammatory microenvironment(opens in new tab/window)

• ●

  Growth differentiation factor-15 and its role in diabetes and cardiovascular disease(opens in new tab/window)

Diabetes Epidemiology and Management

• ●

  PRODIAB: Perspectives on the use of patient-reported outcome measures among diabetic patients(opens in new tab/window)

• ●

  Benefits and limitations of hypo/hyperglycemic alarms associated with continuous glucose monitoring in individuals with diabetes(opens in new tab/window)

Diabetes & Metabolism

• ●

  Empagliflozin cardiovascular and renal effectiveness and safety compared to dipeptidyl peptidase-4 inhibitors across 11 countries in Europe and Asia: Results from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study(opens in new tab/window)

• ●

  Associations of MAFLD and MAFLD subtypes with the risk of the incident myocardial infarction and stroke(opens in new tab/window)

Diabetes and Metabolic Syndrome: Clinical Research & Reviews

• ●

  Empagliflozin improves quality of life in nondiabetic HFrEF patients. Sub-analysis of the EMPATROPISM trial(opens in new tab/window)

• ●

  Cardiovascular and mortality outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: A meta-analysis with the FREEDOM cardiovascular outcomes trial(opens in new tab/window)

Diabetes Research and Clinical Practice

• ●

  Screening, diagnosis and management of diabetic sensorimotor polyneuropathy in clinical practice: International expert consensus recommendations(opens in new tab/window)

• ●

  Worldwide estimates of incidence of type 2 diabetes in children and adolescents in 2021(opens in new tab/window)

Endocrinologia, Diabetes y Nutrición (English version)

• ●

  Metabolic control and treatment regimens in patients with type 1 diabetes in Castilla-La Mancha, 10 years later: The 2020 DIACAM1 study(opens in new tab/window)

• ●

  Epidemiology and resource use in Spanish type 2 diabetes patients without previous cardiorenal disease: CaReMe Spain study summary(opens in new tab/window)

Endocrinología, Diabetes y Nutrición

• ●

  Gestational diabetes prevalence and outcomes in women undergoing assisted reproductive techniques (ART)Prevalencia y resultados de la diabetes gestacional en mujeres sometidas a técnicas de reproducción asistida (TRA)(opens in new tab/window)

• ●

  Relationship between soluble protein ST2 (sST2) levels and microvascular complications in a cohort of patients with type 1 diabetes(opens in new tab/window)

Endocrine and Metabolic Science

• ●

  Associations between metabolic phenotypes and diabetes risk: A systematic review and meta-analysis(opens in new tab/window)

• ●

  The association of aldosterone and endothelin-1 with incident diabetes among African Americans: The Jackson Heart Study(opens in new tab/window)

Endocrine Practice

• ●

  American Association of Clinical Endocrinology Consensus Statement: Comprehensive Type 2 Diabetes Management Algorithm – 2023 Update(opens in new tab/window)

• ●

  American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan—2022 Update(opens in new tab/window)

Growth Hormone & IGF Research

• ●

  Expression of IGF-1 receptor and GH receptor in hepatic tissue of patients with nonalcoholic fatty liver disease and nonalcoholic steatohepatitis(opens in new tab/window)

• ●

  A consensus on optimization of care in patients with growth hormone deficiency and mild traumatic brain injury(opens in new tab/window)

Journal of Clinical and Translational Endocrinology

• ●

  Characteristics, staging and outcomes of differentiated thyroid cancer in patients with and without Graves’ disease(opens in new tab/window)

Journal of Clinical and Translational Endocrinology: Case Reports

• ●

  Hypertriglyceridemia in gestational diabetes: Case report and review of the literature(opens in new tab/window)

Journal of Clinical Densitometry

• ●

  Skin autofluorescence Is associated With low bone mineral density in type 2 diabetic patients(opens in new tab/window)

• ●

  Bone Metabolism Discrepancy in Type 2 Diabetes Mellitus Patients With and Without Non-Alcoholic Fatty Liver Disease(opens in new tab/window)

Journal of Diabetes and its complications

• ●

  Newly diagnosed diabetes vs. pre-existing diabetes upon admission for COVID-19: Associated factors, short-term outcomes, and long-term glycemic phenotypes(opens in new tab/window)

• ●

  Frontiers in diabetic retinal disease(opens in new tab/window)

Metabolism

• ●

  Metformin: Is it a drug for all reasons and diseases?(opens in new tab/window)

• ●

  Insulin: The master regulator of glucose metabolism(opens in new tab/window)

Metabolism Open

• ●

  The effects of gender-affirming hormone therapy on cardiovascular and skeletal health: A literature review(opens in new tab/window)

Molecular and Cellular Endocrinology

• ●

  Maternal diabetes increases FOXO1 activation during embryonic cardiac development(opens in new tab/window)

• ●

  Genetic basis of nephrogenic diabetes insipidus(opens in new tab/window)

Obesity Pillars

• ●

  Obesity, diabetes mellitus, and cardiometabolic risk: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2023(opens in new tab/window)

• ●

  Artificial intelligence and obesity management: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2023(opens in new tab/window)

Obesity Research and Clinical Practice

• ●

  Associations between obesity parameters and hyperuricemia by sex, age, and diabetes mellitus: A nationwide study in Korea(opens in new tab/window)

• ●

  Overweight and obese youth with type 1 or type 2 diabetes share similar elevation in triglycerides during middle and late adolescence(opens in new tab/window)

Peptides

• ●

  The molecular pharmacology of glucagon agonists in diabetes and obesity(opens in new tab/window)

• ●

  Pancreatic polypeptide revisited: Potential therapeutic effects in obesity-diabetes(opens in new tab/window)

Primary Care Diabetes

• ●

  A systematic review and meta-analysis to compare the prevalence of depression between people with and without Type 1 and Type 2 diabetes(opens in new tab/window)

• ●

  Association of community-level food insecurity and glycemic control among pregnant individuals with pregestational diabetes(opens in new tab/window)

Prostaglandins, Leukotrienes and Essential Fatty Acids

• ●

  Placental F4-Neuroprostanes and F2-Isoprostanes are altered in gestational diabetes mellitus and maternal obesity(opens in new tab/window)

• ●

  Omega-3 index and type 2 diabetes: Systematic review and meta-analysis(opens in new tab/window)

Steroids

• ●

  Vascular endothelial dysfunction in gestational diabetes mellitus(opens in new tab/window)

• ●

  Protective effects of combining SERMs with estrogen on metabolic parameters in postmenopausal diabetic cardiovascular dysfunction: The role of cytokines and angiotensin II(opens in new tab/window)

The Journal of Steroid Biochemistry and Molecular Biology

• ●

  Effects of long-term vitamin D supplementation on metabolic profile in middle-aged and elderly patients with type 2 diabetes(opens in new tab/window)

• ●

  The effects of 1,25(OH)2D3 treatment on metabolic reprogramming and maturation in bone marrow-derived dendritic cells from control and diabetic mice(opens in new tab/window)